Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); Think This Stock Still Has Legs
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $803.48 -0.31%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Baird reiterates an 'Outperform' on Regeneron Pharma (NASDAQ: REGN) price target raised from $100 to $110.
Baird analyst says, "With shares up 55% since EYLEA's blow-out Q411 pre-release, we acknowledge the urge to take profits here. However, after raising our EYLEA estimates to reflect a stronger launch (layering in DME, greater AMD share gains); we now believe fair value is closer to $110/share. Therefore, we remain buyers."
"We are also modestly raising our numbers in wet AMD to reflect increased share gains at the expense of Lucentis. Our new FY13-FY15 US EYLEA revenue estimates are $409M, $671M and $1.04B, respectively."
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $101.14 yesterday.
Baird analyst says, "With shares up 55% since EYLEA's blow-out Q411 pre-release, we acknowledge the urge to take profits here. However, after raising our EYLEA estimates to reflect a stronger launch (layering in DME, greater AMD share gains); we now believe fair value is closer to $110/share. Therefore, we remain buyers."
"We are also modestly raising our numbers in wet AMD to reflect increased share gains at the expense of Lucentis. Our new FY13-FY15 US EYLEA revenue estimates are $409M, $671M and $1.04B, respectively."
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $101.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
